Skip to content
Back to outputs

Azo compounds in colon-specific drug delivery

Research output: Contribution to journalArticlepeer-review

Standard

Azo compounds in colon-specific drug delivery. / Roldo, Marta; Barbu, Eugen; Brown, James; Laight, David; Smart, John D.; Tsibouklis, John.

In: Expert Opinion on Drug Delivery, Vol. 4, No. 5, 09.2007, p. 547-560.

Research output: Contribution to journalArticlepeer-review

Harvard

Roldo, M, Barbu, E, Brown, J, Laight, D, Smart, JD & Tsibouklis, J 2007, 'Azo compounds in colon-specific drug delivery', Expert Opinion on Drug Delivery, vol. 4, no. 5, pp. 547-560. https://doi.org/10.1517/17425247.4.5.547

APA

Vancouver

Author

Roldo, Marta ; Barbu, Eugen ; Brown, James ; Laight, David ; Smart, John D. ; Tsibouklis, John. / Azo compounds in colon-specific drug delivery. In: Expert Opinion on Drug Delivery. 2007 ; Vol. 4, No. 5. pp. 547-560.

Bibtex

@article{c1933414daa049568fa5de61cc5cb23b,
title = "Azo compounds in colon-specific drug delivery",
abstract = "Azo compounds have the potential to act as drug carriers that facilitate the selective release of therapeutic agents to the colon, and also to effect the oral administration of those macromolecular drugs that require colon-specific drug delivery. With some further research-driven refinements, these materials may lead to more efficient treatments for local conditions, such as colonic cancer or inflammatory bowel disease. This article provides an overview of the azo-based systems developed to date, identifies the requirements for an ideal carrier, and highlights the directions for further developments in the field of azo group-facilitated colonic delivery.",
author = "Marta Roldo and Eugen Barbu and James Brown and David Laight and Smart, {John D.} and John Tsibouklis",
year = "2007",
month = sep,
doi = "10.1517/17425247.4.5.547",
language = "English",
volume = "4",
pages = "547--560",
journal = "Expert Opinion on Drug Delivery",
issn = "1742-5247",
publisher = "Informa Healthcare",
number = "5",

}

RIS

TY - JOUR

T1 - Azo compounds in colon-specific drug delivery

AU - Roldo, Marta

AU - Barbu, Eugen

AU - Brown, James

AU - Laight, David

AU - Smart, John D.

AU - Tsibouklis, John

PY - 2007/9

Y1 - 2007/9

N2 - Azo compounds have the potential to act as drug carriers that facilitate the selective release of therapeutic agents to the colon, and also to effect the oral administration of those macromolecular drugs that require colon-specific drug delivery. With some further research-driven refinements, these materials may lead to more efficient treatments for local conditions, such as colonic cancer or inflammatory bowel disease. This article provides an overview of the azo-based systems developed to date, identifies the requirements for an ideal carrier, and highlights the directions for further developments in the field of azo group-facilitated colonic delivery.

AB - Azo compounds have the potential to act as drug carriers that facilitate the selective release of therapeutic agents to the colon, and also to effect the oral administration of those macromolecular drugs that require colon-specific drug delivery. With some further research-driven refinements, these materials may lead to more efficient treatments for local conditions, such as colonic cancer or inflammatory bowel disease. This article provides an overview of the azo-based systems developed to date, identifies the requirements for an ideal carrier, and highlights the directions for further developments in the field of azo group-facilitated colonic delivery.

U2 - 10.1517/17425247.4.5.547

DO - 10.1517/17425247.4.5.547

M3 - Article

VL - 4

SP - 547

EP - 560

JO - Expert Opinion on Drug Delivery

JF - Expert Opinion on Drug Delivery

SN - 1742-5247

IS - 5

ER -

ID: 142484